User profiles for S. Rod Rassekh

Shahrad Rod Rassekh

University of British Columbia; BC Childrens Hospital
Verified email at cw.bc.ca
Cited by 4281

Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children

H Visscher, CJD Ross, SR Rassekh… - Journal of clinical …, 2012 - ascopubs.org
Purpose Anthracycline-induced cardiotoxicity (ACT) is a serious adverse drug reaction limiting
anthracycline use and causing substantial morbidity and mortality. Our aim was to identify …

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

…, H Katzov-Eckert, MP Dubé, B Brooks, SR Rassekh… - Nature …, 2009 - nature.com
Cisplatin is a widely used and effective chemotherapeutic agent, although its use is restricted
by the high incidence of irreversible ototoxicity associated with it 1 . In children, cisplatin …

[HTML][HTML] Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR

M Alcaide, M Cheung, J Hillman, SR Rassekh… - Scientific reports, 2020 - nature.com
Cell-free DNA (cfDNA) has become a comprehensive biomarker in the fields of non-invasive
cancer detection and monitoring, organ transplantation, prenatal genetic testing and …

Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers

…, E Pleasance, SR Rassekh… - Molecular …, 2015 - molecularcasestudies.cshlp.org
Given the success of targeted agents in specific populations it is expected that some degree
of molecular biomarker testing will become standard of care for many, if not all, cancers. To …

Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children

H Visscher, SR Rassekh, GS Sandor… - …, 2015 - Future Medicine
Aim: To identify novel variants associated with anthracycline-induced cardiotoxicity and to
assess these in a genotype-guided risk prediction model. Patients & methods: Two cohorts …

Comparative tumor RNA sequencing analysis for difficult-to-treat pediatric and young adult patients with cancer

…, A Plant, I Kirov, KB Zabokrtsky, SR Rassekh… - JAMA network …, 2019 - jamanetwork.com
Importance Pediatric cancers are epigenetic diseases; therefore, considering tumor gene
expression information is necessary for a complete understanding of the tumorigenic processes…

Abnormal liver transaminases and conjugated hyperbilirubinemia at presentation of acute lymphoblastic leukemia

I Segal, SR Rassekh, MC Bond, C Senger… - Pediatric blood & …, 2010 - Wiley Online Library
Background Acute lymphoblastic leukemia (ALL) is the most common malignancy in
childhood. While hepatitis is a well‐known complication during the treatment phase of ALL, the …

Cannabinoids for symptom management in children with cancer: A systematic review and meta‐analysis

…, S Oberoi, N Bradford, A Bowers, SR Rassekh… - Cancer, 2023 - Wiley Online Library
S. Rod Rassekh receives research project funding from the Canadian Institutes of Health
Research and the BC Children’s Hospital Foundation to study medical cannabis in children. …

VKORC1 and CYP2C9 genotypes are predictors of warfarin‐related outcomes in children

…, U Amstutz, C Hildebrand, SR Rassekh… - Pediatric blood & …, 2014 - Wiley Online Library
Background Despite substantial evidence supporting a pharmacogenetic approach to warfarin
therapy in adults, evidence on the importance of genetics in warfarin therapy in children …

[HTML][HTML] Pharmacogenomics of serious adverse drug reactions in pediatric oncology

CJD Ross, H Visscher, SR Rassekh… - Journal of Population …, 2011 - jptcp.com
Adverse drug reactions (ADRs) rank as one of the top ten leading causes of death and illness
in the developed world. In cancer therapy, more patients are surviving cancer than ever …